Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
patent expiry for GLP-1 drugs across markets Company Molecule Brand Name Mode of administration First US Patent Expiry Canada Brazil India Novo Semaglutide Ozempic Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Wegovy Injectable 2031 Jan 2026 Mar 2026 Mar 2026 Novo Semaglutide Rybelsus Oral 2031 Jan 2026 Mar 2026 Mar 2026 Eli Lilly Tirzepatide Mounjaro Injectable 2036 2036 2036 2036 Eli Lilly Tirzepatide Zepbound Injectable 2036 2036 2036 2036 Positioning of Indian Pharma companies in GLP-1s company positioning Shaily Engineering Leading manufacturer of pen injectors for GLP-1 therapies
That is very different from a prescription label, which tells clinicians how an approved medication may be used in routine care
According to the study, 78 ethnomedicinal plant species belonging to 45 different families are used to treat GI disorders in Himachal Pradesh
A., O'Malley, E., et al
People using this medication still need routine glucose monitoring, A1C checks, nutrition planning, and regular follow-up for diabetes care
US$ 27.14
US$ 29.24
US$ 20.86
